What is it about?
In this paper, we review the current evidence dealing with the use of Rituximab therapy in adult patients with primary glomerular diseases.
Featured Image
Read the Original
This page is a summary of: Rituximab use in adult primary glomerulopathy: where is the evidence?, Therapeutics and Clinical Risk Management, August 2016, Dove Medical Press,
DOI: 10.2147/tcrm.s114316.
You can read the full text:
Contributors
The following have contributed to this page